Congestive Heart Failure Treatment Devices Market Size Report, 2032

Congestive Heart Failure (CHF) Treatment Devices Market - By Product (Defibrillator [ICD, External], Pacemaker, Cardiac Resynchronization Therapy Device, Ventricular Assist Device [LVAD, RVAD]), End-use (Hospital, Cardiac Clinic) – Global Forecast 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rising prevalence of heart failure and cardiovascular diseases

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancements and introduction of innovative devices

3.2.1.3&nbsp;&nbsp;&nbsp;Favorable reimbursement scenario

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing awareness regarding heart failure treatment

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of devices

3.2.2.2&nbsp;&nbsp;&nbsp;Product recalls

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.4.1&nbsp;&nbsp;&nbsp; Supplier power

3.4.2&nbsp;&nbsp;&nbsp; Buyer power

3.4.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.4.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.4.5&nbsp;&nbsp;&nbsp; Industry rivalry

3.5&nbsp;&nbsp;&nbsp; PESTEL analysis

3.6&nbsp;&nbsp;&nbsp; Pricing analysis, 2023

3.7&nbsp;&nbsp;&nbsp; Number of heart failures at global and regional, 2023

3.8&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.9&nbsp;&nbsp;&nbsp; Regulatory landscape

3.10&nbsp;&nbsp;&nbsp; Technological landscape

3.11&nbsp;&nbsp;&nbsp; Pipeline products

3.12&nbsp;&nbsp;&nbsp; Future market trends

3.13&nbsp;&nbsp;&nbsp; Gap analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2018 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Defibrillators

5.2.1&nbsp;&nbsp;&nbsp; Implantable cardioverter defibrillators (ICDs)

5.2.1.1&nbsp;&nbsp;&nbsp;Transvenous ICD

5.2.1.1.1&nbsp;&nbsp;&nbsp; Single-chamber ICDs

5.2.1.1.2&nbsp;&nbsp;&nbsp; Dual-chamber ICDs

5.2.1.2&nbsp;&nbsp;&nbsp;Subcutaneous ICD

5.2.2&nbsp;&nbsp;&nbsp; External cardioverter defibrillator

5.2.2.1&nbsp;&nbsp;&nbsp;Manual external defibrillator

5.2.2.2&nbsp;&nbsp;&nbsp;Automated external defibrillator

5.2.2.2.1&nbsp;&nbsp;&nbsp; Semi-automated external defibrillator

5.2.2.2.2&nbsp;&nbsp;&nbsp; Fully automated external defibrillator

5.2.2.3&nbsp;&nbsp;&nbsp;Wearable external cardioverter defibrillator

5.3&nbsp;&nbsp;&nbsp; Pacemakers

5.3.1&nbsp;&nbsp;&nbsp; Implantable pacemakers

5.3.2&nbsp;&nbsp;&nbsp; External pacemakers

5.4&nbsp;&nbsp;&nbsp; Cardiac resynchronization therapy devices

5.4.1&nbsp;&nbsp;&nbsp; Cardiac resynchronization therapy-defibrillators (CRT-D)

5.4.1.1&nbsp;&nbsp;&nbsp;MRI compatible CRT-D devices

5.4.1.2&nbsp;&nbsp;&nbsp;Conventional CRT-D devices

5.4.2&nbsp;&nbsp;&nbsp; Cardiac resynchronization therapy-pacemakers (CRT-P)

5.4.2.1&nbsp;&nbsp;&nbsp;MRI Compatible CRT-P devices

5.4.2.2&nbsp;&nbsp;&nbsp;Conventional CRT-P devices

5.5&nbsp;&nbsp;&nbsp; Ventricular assist devices (VADs)

5.5.1&nbsp;&nbsp;&nbsp; Left ventricular assist devices (LVADs)

5.5.2&nbsp;&nbsp;&nbsp; Right ventricular assist devices (RVADs)

5.5.3&nbsp;&nbsp;&nbsp; Biventricular assist devices (BIVADs)

5.5.4&nbsp;&nbsp;&nbsp; Percutaneous ventricular assist devices (PVADs)

5.5.5&nbsp;&nbsp;&nbsp; Total artificial heart

5.6&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2018 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Hospitals

6.3&nbsp;&nbsp;&nbsp; Cardiac clinics

6.4&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

6.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2018 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Italy

7.3.5&nbsp;&nbsp;&nbsp; Spain

7.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

7.6&nbsp;&nbsp;&nbsp; Middle East and Africa

7.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.2&nbsp;&nbsp;&nbsp; South Africa

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.2&nbsp;&nbsp;&nbsp; Biotronik SE &amp; Co. KG

8.3&nbsp;&nbsp;&nbsp; Boston Scientific Corporation

8.4&nbsp;&nbsp;&nbsp; Koninkilijke Philips N.V.

8.5&nbsp;&nbsp;&nbsp; Lepu Medical Technology Co. Ltd.

8.6&nbsp;&nbsp;&nbsp; LivaNova PLC

8.7&nbsp;&nbsp;&nbsp; MEDICO S.p.A.

8.8&nbsp;&nbsp;&nbsp; Medtronic plc

8.9&nbsp;&nbsp;&nbsp; MicroPort Scientific Corporation

8.10&nbsp;&nbsp;&nbsp; OSCOR Inc.

8.11&nbsp;&nbsp;&nbsp; Schiller AG

8.12&nbsp;&nbsp;&nbsp; Shree Pacetronix Ltd.

8.13&nbsp;&nbsp;&nbsp; St. Jude Medical, Inc.

8.14&nbsp;&nbsp;&nbsp; Stryker Corporation

8.15&nbsp;&nbsp;&nbsp; Terumo Corporation 
&nbsp;

Congestive Heart Failure (CHF) Treatment Devices Market

Inquiry Before Buying